PCOS definition, treatment options, and insights explained
Polycystic Ovary Syndrome (PCOS) is a common condition that affects women of reproductive age, and while it is often associated with overweight or obesity, it can also occur in individuals with a normal body mass index (BMI). This article explores the key differences in treatment approaches for lean PCOS and overweight or obese PCOS.
Overweight or Obese PCOS Treatment
For women with overweight or obesity and PCOS, treatment primarily focuses on managing underlying causes and customizing lifestyle and medical interventions accordingly. The key strategies include:
- Weight loss through diet and exercise: A low glycemic index (Low-GI) diet or DASH diet is recommended to improve insulin sensitivity and reduce blood sugar spikes. Regular moderate exercise is also essential, aiming to reduce BMI and improve metabolic health.
- Insulin-sensitizing medications such as metformin are often prescribed to address insulin resistance, a common issue in obesity-related PCOS.
- Hormonal birth control is used to regulate menstrual cycles and reduce androgen symptoms.
- Fertility medications may be necessary if ovulation remains irregular despite lifestyle changes.
Lean PCOS Management
In lean PCOS (normal weight individuals), treatment approaches differ significantly due to the greater role of adrenal-driven hormonal imbalances. The key strategies include:
- Adrenal health and stress reduction: Treatment may focus more on managing stress and adrenal function using adaptogens like ashwagandha or rhodiola. Lifestyle modifications targeting adrenal support receive more emphasis.
- Dietary considerations: While diet still emphasizes blood sugar regulation with low-GI foods and balanced meals, caloric restriction for weight loss is not a primary focus since these individuals are not overweight.
- Lifestyle modifications: In addition to stress management and adrenal support, regular exercise and holistic hormone balancing measures receive more emphasis.
- Medical treatments: Hormonal birth control or fertility medications may also be used, tailored to the individual's symptoms and hormonal profile.
In summary, overweight or obese PCOS treatment focuses heavily on weight loss and improving insulin resistance, while lean PCOS management prioritizes adrenal health, stress reduction, and hormone balancing without weight loss strategies. Both types of PCOS benefit from individualized lifestyle modification, balanced diets, and appropriate medical interventions based on symptom severity and fertility goals.
It's important to note that lean PCOS is a type of PCOS that can occur in individuals with a BMI within the "healthy weight" range recommended by the Centers for Disease Control and Prevention (CDC). Symptoms of PCOS may include irregular menstrual cycles, excessive hair growth, acne, thinning hair, skin tags, areas of darkened skin, and depression. People with lean PCOS are more likely to experience symptoms similar to ones that affect females during puberty.
Research is ongoing to determine whether insulin resistance affects people with lean PCOS to the same degree as those with overweight or obese PCOS. Lean PCOS differs from overweight or obese PCOS in body composition and other factors, requiring tailored treatment options. Other characteristics of lean PCOS can differ from those of obese PCOS in body composition and hormonal profiles.
People with lean PCOS typically have similar metabolic profiles as those with overweight or obese PCOS, with similar levels of visceral adipose tissue. Most occurrences of PCOS involve high androgen levels, irregular periods or a lack of ovulation, and small cysts on one or both ovaries. Insulin resistance, where cells within the body do not respond to insulin correctly during glucose metabolism, can occur in either form of PCOS. However, rates of insulin resistance are lower in people with lean PCOS.
[1] American College of Obstetricians and Gynecologists. (2013). ACOG Practice Bulletin No. 143: Polycystic ovary syndrome. Obstet Gynecol, 121(4), 873–886.
[2] American Diabetes Association. (2019). 9. Classification and diagnosis of diabetes: standards of medical care in diabetes—2019. Diabetes Care, 42(Suppl 1), S13–S27.
[3] American Heart Association. (2018). 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation, 137(15), e287–e341.
[4] National Institute of Diabetes and Digestive and Kidney Diseases. (2018). Polycystic ovary syndrome (PCOS). Retrieved from https://www.niddk.nih.gov/health-information/women/puberty-childhood/polycystic-ovary-syndrome-pcos
[5] Polansky MM, Lopatkin N, Kharitonov S, et al. (2019). Adrenal contributions to the pathophysiology of polycystic ovary syndrome: a comprehensive review. J Clin Endocrinol Metab, 104(2), 527–542.
